Daniel P Teufel - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Daniel P Teufel

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Journal of Medicinal Chemistry|March 24, 2020

Identification and Optimization of EphA2-Selective Bicycles for the Delivery of Cytotoxic PayloadsGemma E Mudd, Amy Brown, Liuhong Chen, et al.

Journal of Medicinal Chemistry|March 9, 2018

Stable and Long-Lasting, Novel Bicyclic Peptide Plasma Kallikrein Inhibitors for the Treatment of Diabetic Macular EdemaDaniel P Teufel, Gavin Bennett, Helen Harrison, et al.

Cancer Research|January 5, 2019

Bicyclic Peptides as a New Modality for Imaging and Targeting of Proteins Overexpressed by TumorsMatthias Eder, Silvia Pavan, Ulrike Bauder-Wüst, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Journal of Medicinal Chemistry|March 24, 2020

Identification and Optimization of EphA2-Selective Bicycles for the Delivery of Cytotoxic PayloadsGemma E Mudd, Amy Brown, Liuhong Chen, et al.

Journal of Medicinal Chemistry|March 9, 2018

Stable and Long-Lasting, Novel Bicyclic Peptide Plasma Kallikrein Inhibitors for the Treatment of Diabetic Macular EdemaDaniel P Teufel, Gavin Bennett, Helen Harrison, et al.

Cancer Research|January 5, 2019

Bicyclic Peptides as a New Modality for Imaging and Targeting of Proteins Overexpressed by TumorsMatthias Eder, Silvia Pavan, Ulrike Bauder-Wüst, et al.

Pageof 2